CXF-007
CXF-007 is a potent and specific FGFR4 inhibitor with a IC50 value of 7 nM. CXF-007 has antitumor activity.
For research use only. We do not sell to patients.
- CAS No.: 2727083-99-8
- Formula: C34H33N7O5
- Molecular Weight:619.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
|
FGFR4 7 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | IC50 |
>5000 nM
Compound: CXF-007
|
Antiproliferative activity against mouse BaF3 cells incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
1 nM
Compound: CXF-007
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR4 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR4 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
170 nM
Compound: CXF-007
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR3 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR3 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
445 nM
Compound: CXF-007
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR2 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR2 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| BaF3 | IC50 |
530 nM
Compound: CXF-007
|
Antiproliferative activity against mouse BaF3 cells expressing FGFR1 incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against mouse BaF3 cells expressing FGFR1 incubated for 72 hrs by CCK-8 assay
|
[PMID: 38432058] |
| HCC1937 | IC50 |
3.36 μM
Compound: CXF-007
|
Antiproliferative activity against human HCC1937 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human HCC1937 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| Hep 3B2 | IC50 |
0.77 μM
Compound: CXF-007
|
Antiproliferative activity against human Hep3B cells after 72 hrs by CCK8 assay
Antiproliferative activity against human Hep3B cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| Huh-7 | IC50 |
1.16 μM
Compound: CXF-007
|
Antiproliferative activity against human Huh-7 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human Huh-7 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| MDA-MB-453 | IC50 |
0.37 μM
Compound: CXF-007
|
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human MDA-MB-453 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
| NCI-H1299 | IC50 |
>10 μM
Compound: CXF-007
|
Antiproliferative activity against human NCI-H1299 cells after 72 hrs by CCK8 assay
Antiproliferative activity against human NCI-H1299 cells after 72 hrs by CCK8 assay
|
[PMID: 38432058] |
Chemical Information
-
CAS No. 2727083-99-8
-
Molecular Weight 619.67
-
Formula C34H33N7O5
-
SMILES
COC1=CC(OC)=CC(N(C2)C(N(CCC3=CC=C(NC(C=C)=O)C=C3)C4=C2C=NC(NC5=C(NC(C=C)=O)C=CC=C5)=N4)=O)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)